Affiliation:
1. Departments of Pediatrics,
2. Gastroenterology, and
3. Pathology, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan
Abstract
Primary intestinal lymphangiectasia (PIL), also known as Waldmann’s disease, is an exudative enteropathy resulting from morphologic abnormalities in the intestinal lymphatics. In this article, we describe a 12-year-old boy with PIL that led to protein-losing enteropathy characterized by diarrhea, hypoalbuminemia associated with edema (serum albumin level: 1.0 g/dL), and hypogammaglobulinemia (serum IgG level: 144 mg/dL). Severe hypoalbuminemia, electrolyte abnormalities, and tetany persisted despite a low-fat diet and propranolol. Everolimus (1.6 mg/m2/day) was added to his treatment as an antiangiogenic agent. With everolimus treatment, the patient’s diarrhea resolved and replacement therapy for hypoproteinemia was less frequent. Hematologic and scintigraphy findings also improved (serum albumin level: 2.5 g/dL). There were no adverse reactions during the 12-month follow-up. To the best of our knowledge, this is the first report of everolimus use in a patient with PIL.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference19 articles.
1. Complex lymphatic anomalies.;Trenor;Semin Pediatr Surg,2014
2. International Society for the Study of Vascular Anomalies
. ISSVA classification for vascular anomalies. Available at: www.issva.org. Accessed May 2, 2015
3. Pediatric lymphangiectasia: an imaging spectrum.;Malone;Pediatr Radiol,2015
4. Primary intestinal lymphangiectasia (Waldmann’s disease).;Vignes;Orphanet J Rare Dis,2008
5. Disorders of absorption;Binder,2001
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献